Your browser doesn't support javascript.
loading
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.
Herbert, Katharine J; Ashton, Thomas M; Prevo, Remko; Pirovano, Giacomo; Higgins, Geoff S.
Afiliação
  • Herbert KJ; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK. katharine.herbert@oncology.ox.ac.uk.
  • Ashton TM; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
  • Prevo R; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
  • Pirovano G; Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Higgins GS; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.
Cell Death Dis ; 9(11): 1089, 2018 10 24.
Article em En | MEDLINE | ID: mdl-30356039

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinoxalinas / Tiofenos / Quinolonas / Quinases de Proteína Quinase Ativadas por Mitógeno / Terapia de Alvo Molecular / Indolizinas / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinoxalinas / Tiofenos / Quinolonas / Quinases de Proteína Quinase Ativadas por Mitógeno / Terapia de Alvo Molecular / Indolizinas / Neoplasias Limite: Animals / Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido